about
Intermittent self-dilatation for urethral stricture disease in malesUrodynamic assessment of urinary incontinence.The surgical treatment of female stress urinary incontinence.Surgical treatment for stress urinary incontinence.Individualized volume-corrected maximum flow rate correlates with outcome from bladder outlet surgery in men with lower urinary tract symptoms.The penile cuff test: A clinically useful non-invasive urodynamic investigation to diagnose men with lower urinary tract symptomsReconstructing the lower urinary tract: The Mitrofanoff principleIntermittent self-dilatation for urethral stricture disease in males: A systematic review and meta-analysis.Male bladder outlet obstruction: Time to re-evaluate the definition and reconsider our diagnostic pathway? ICI-RS 2015.Augmentation cystoplasty: Contemporary indications, techniques and complications.Predicting the outcome of prostatectomy using noninvasive bladder pressure and urine flow measurements.Qualitative Exploration of the Patient Experience of Underactive Bladder.Detrusor after-contraction on ambulatory urodynamics in symptomatic women.Differences in urodynamic voiding variables recorded by conventional cystometry and ambulatory monitoring in symptomatic women.Discontinuation rates and inter-injection interval for repeated intravesical botulinum toxin type A injections for detrusor overactivity.Is low bladder compliance predictive of detrusor overactivity?How can we maximize the diagnostic utility of uroflow?: ICI-RS 2017.Non-antibiotic options for recurrent urinary tract infections in women.Male synthetic sling versus artificial urinary sphincter trial for men with urodynamic stress incontinence after prostate surgery (MASTER): study protocol for a randomised controlled trial.Should I stay or should I go? A qualitative study exploring participation in a urology clinical trialCan filling phase urodynamic parameters predict the success of the bulbar artificial urinary sphincter in treating post-prostatectomy incontinence?A systematic approach to the investigation and treatment of nocturiaDetailed analysis of patient-reported lower urinary tract symptoms and effect on quality of life after robotic radical prostatectomyDo we understand voiding dysfunction in women? Current understanding and future perspectives: ICI-RS 2017Reply to Bora Lee and Jae Heon Kim's Letter to the Editor re: Alan D. Uren, Nikki Cotterill, Christopher Harding, et al. Qualitative Exploration of the Patient Experience of Underactive Bladder. Eur Urol 2017;72:402–7Urinary tract infection management – do the guidelines agree?What research is needed to validate new urodynamic methods? ICI-RS2017Publication rate of abstracts presented at the British Association of Urological Surgeons Annual Meeting – 10 years onRenal traumaReply from Authors re: Mikkel Fode, Jens Sønksen. Towards a Greater Understanding of Underactive Bladder. Eur Urol 2017;72:408–9Posterior tibial nerve stimulation in adults with overactive bladder syndrome: A systematic review of the literatureThe role of uroflowmetry in the assessment and management of men with lower urinary tract symptoms – revisiting the evidenceAuthors' Response to Valentini FA, Nelson PP. Letter to the Editor. Neurourol Urodyn 2013;32:505Quantifying the effect of urodynamic catheters on urine flow rate measurementRISK OF URINARY TRACT INFECTION AFTER DETRUSOR BOTULINUM TOXIN A INJECTIONS FOR REFRACTORY NEUROGENIC DETRUSOR OVERACTIVITY IN PATIENTS WITH NO ANTIBIOTIC TREATMENTAuricular acupuncture: a novel treatment for vasomotor symptoms associated with luteinizing-hormone releasing hormone agonist treatment for prostate cancerHistological upgrading and upstaging in the UK population following radical prostatectomy and their implications for active surveillancePredictors of cancer on repeat prostate biopsy: A contemporary UK seriesCategorization of Obstruction Using Noninvasive Pressure Flow Measurements: Sensitivity to Change Following ProstatectomyVariation in Invasive and Noninvasive Measurements of Isovolumetric Bladder Pressure and Categorization of Obstruction According to Bladder Volume
P50
Q24187167-10AF95D0-BCD8-42B1-A880-80CB8E8CC343Q34124007-703B04CA-11F6-491B-98F7-8B7253ED66C3Q34124051-6933BE25-988E-4791-A04F-553D2BEEBA62Q37053889-9243E5C5-ABF7-4543-BFA0-3C6A30F8A2A5Q37164699-BAABDF47-5E69-4A6B-A182-4DF00E7B81D6Q37197681-CBBA0885-E647-4B87-BC83-77FBC8D1DAF9Q37293386-CE5BB540-6C75-4DF5-8376-DDE91DFFD0CBQ38533316-0300869F-4C4F-4C30-805B-B266F509293FQ38690694-B9D8F3FD-5842-4657-9602-A9640255B179Q39314841-F6E566D6-F7AF-4087-AE5F-DA8339C20888Q39343446-3A3E2A56-3661-41AE-8758-A05B9F2C6ABAQ40255357-42EF4F22-61BA-4FDB-8DDF-B4BC514824CCQ41458891-14A36894-ECDB-4C49-A0CE-86ECFE6A89CEQ41701126-B0F79E1B-A1C7-4660-B41F-54769CDD72F9Q44739294-5F36C86B-C24B-445E-BF8C-107B367FD306Q46977399-A4653A2F-CA76-4FFF-B80D-ABA349D0F44AQ48282177-130F3426-BBB7-40AA-8A69-990D659880F0Q49691564-4C1A9637-D23B-4DAA-9744-9BAA038425F0Q50308970-2C86694E-F02F-4230-961F-FA7E8DEA4AF4Q57453381-F5449F59-88B3-414A-98FB-EFBB0F20B568Q57824557-E452057B-9BA8-45E2-9A9F-1D53D8EC65B4Q58461175-39B6CE2E-D94B-4A91-9520-70BB035E9520Q58461177-46FDCF7C-3C36-4D6B-86C2-0DB2FEF8204FQ58461180-BA717A00-7F47-4675-9C5C-A06ED715B864Q58461185-9AB85678-627E-4D9C-827B-0FB3C10DE59EQ58461190-6C9CBE79-0968-43D1-8D7A-384B403450D1Q58461193-D1834BAE-BBBE-4775-8CF7-F150129932D4Q58461198-0F3F0B07-880C-4B81-8A98-B24517FCA0ECQ58461204-1EBD56A2-AA24-4DAB-B590-FAE4BDBCD0F6Q58461207-2B547581-BB48-4060-8C0B-23B97233ADDBQ58461210-87BC5523-5947-4919-B4CB-3EDDD539FD3CQ58461216-7062C8FC-C297-41FA-99D4-3DAC0679F02BQ58461219-E18EE5E0-68CF-438D-AAE7-952AAEB4EA7DQ58461226-FF50C73D-C82B-4C15-B708-C05170339187Q58461229-0B2617BB-BD93-4FFA-9828-31F546024976Q58461236-EEC3E5EC-D1D8-4A99-B99C-E62963E7DD7FQ58461238-BABAAD1F-D4FA-4E64-B368-4945944260C7Q58461242-5ED73F76-99B0-4736-B856-E72732BABEA6Q58461244-805BED7A-993B-4398-897D-26932E57ECD8Q58461249-4EEFC1F2-F783-415A-B069-3FEF247FF752
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-9407-382X
@en
name
Chris Harding
@ast
Chris Harding
@en
Chris Harding
@es
Chris Harding
@nl
type
label
Chris Harding
@ast
Chris Harding
@en
Chris Harding
@es
Chris Harding
@nl
prefLabel
Chris Harding
@ast
Chris Harding
@en
Chris Harding
@es
Chris Harding
@nl
P106
P1153
8933960100
P31
P496
0000-0002-9407-382X